|
Variables
|
MPA(n = 55)
|
LA(n = 76)
|
p
|
|---|
|
Single alteration
| | |
0.028*
|
|
EGFR +
|
40(72.7%)
|
41(53.9%)
| |
|
ROS1 +
|
2(3.6%)
|
0
| |
|
EML4-ALK+
|
1(1.8%)
|
1(1.3%)
| |
|
Double alteration
| | |
0.043*
|
|
EGFR+; ROS1+
|
2(3.6%)
|
1(1.3%)
| |
|
ROS1+; EML4-ALK+
|
2(3.6%)
|
0
| |
|
No alteration
| | |
0.001**
|
|
EGFR-; ROS1-; EML4-ALK-
|
8(14.5%)
|
33(43.5%)
| |
- MPA micropapillary lung adenocarcinoma, LA lung adenocarcinoma without micropapillary component, EGFR+ EGFR mutation, EGFR- EGFR wild type, ROS1+ ROS1 fusion, ROS1- no ROS1 fusion, EML4-ALK+ EML4-ALK fusion, EML4-ALK- no EML4-ALK fusion
- *p<0.05; **p<0.01 compared with LA
